FLNA - Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc.

FLNA
โš•๏ธ Healthcare NASDAQ Listed 2000 $ USD
$1,000 invested 20 years ago โ†’$14today

Score Overview

1 Year
Scoreโ€”
Net Growth53.61%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-30.30%
Net Trend40%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-184.17%
Net Trend50%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency
20 Years
Score1.4
Net Growth-6x
Net Trend40%
Net Income Consistency
Rev Growth-100.00%
Rev Trend18%
Revenue Consistency
All Time
Score
Net Growth-6x
Net Trend40%
Net Income Consistency
Rev Growth-100.00%
Rev Trend18%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Filana Therapeutics, Inc. has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. FLNA does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-17
$ 0.48โ€”
1 Year2025-11-17
$ 2.78-82.70%
5 Years2021-11-17
$ 47.07-98.98%
10 Years2016-11-17
$ 4.20-88.55%
20 Years2006-11-17
$ 35.61-98.65%
All Time2000-07-14
$ 89.24-99.46%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 0.00-$ 42M$ 46M
2025$ 0.00-$ 90M$ 95M
2024$ 0.00-$ 24M$ 128M
2023$ 0.00-$ 97M$ 121M
2022$ 0.00-$ 76M$ 201M
2021-$ 32M$ 233M
2020-$ 6M$ 93M
2019-$ 4M$ 23M
2018-$ 6M$ 19M
2017-$ 11M$ 10M
2016-$ 14M$ 18M
2015-$ 14M$ 31M
2014-$ 12M$ 40M
2013$ 41M$ 31M$ 49M
2012$ 10M-$ 3M$ 56M
2011$ 11M-$ 2M$ 98M
2010$ 16M-$ 12M$ 91M
2009$ 20M-$ 3M$ 175M
2008$ 63M$ 15M$ 190M
2007$ 65M$ 20M$ 205M
2006$ 53M$ 6M$ 204M
FLNA - Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. fundamental performance

Across Filana Therapeutics, Inc.'s full reported history, from 2006 to 2025, revenue declined from $ 53M to $ 0.00 and net income went from $ 6M to -$ 90M. Revenue increased in 18% of the years measured; net income in 40%.

Filana Therapeutics, Inc. currently holds a 20-year HDB Score of 1.4 out of 10. How the HDB Score is calculated.

Membership

Explore FLNA with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,187 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies